Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Beverly Hills, California 90210


Purpose:

Study is intended to evaluate safety and efficacy parameters in patients treated with GLYC-101 gel or placebo after laser ablation.


Study summary:

The proposed pilot-study will document feasibility, safety and efficacy of topically applied Glucoprime gel (GLYC-101 gel 1.0 %) in promoting wound healing in healthy volunteer subjects undergoing retro-auricular Carbon Dioxide Laser Skin Resurfacing (CO2 LSR). The study will observe the effects of the topical agent over the course of 1 month following the treatment. as a preparation for study GLYC-101-1b (Double-blind, randomized, placebo-controlled Phase 2 Pilot Study to investigate the safety and efficacy of 1.0 % topically applied GLYC 101 compared to placebo, in patients undergoing Carbon Dioxide Laser Skin Resurfacing).


Criteria:

Inclusion Criteria: Subjects meeting all of the following criteria will be considered for admission to the study: - Patients giving informed consent for retro-auricular laser ablation between 25 and 55 years old. - Retro-auricular area is free of any irritation, scars or dermatologic conditions which might interfere with the study. - Willing and able to participate in the study and follow all study directions. - Able to read, understand and sign the consent form. Exclusion Criteria: - Pregnant, nursing, or planning a pregnancy during the course of the study, as determined by the interview and a urine pregnancy test. - Systemic or cutaneous disease that may interfere with the study results. - Presence of irritation or dermatologic skin conditions in the retro-auricular area. - Known allergies to materials within the test formulations. - Systemic or cutaneous therapy with medication that impacts wound healing (steroids, immune modulators, immune suppressants).


NCT ID:

NCT00656474


Primary Contact:

Principal Investigator
John Joseph, MD
CLINICAL TESTING CENTER of BEVERLY HILLS


Backup Contact:

N/A


Location Contact:

Beverly Hills, California 90210
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 20, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.